MALLORY AVANT: Open Payments
NPI 1942953419 · MUSCLE SHOALS, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,344 in 76 payments from 15 companies in 2025. Trend: 2023 $1,271 · 2024 $992 · 2025 $1,344
Food & beverage: $1,344
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 10 | $208 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $193 |
| ABBVIE INC. | 19 | $190 |
| Vanda Pharmaceuticals Inc. | 7 | $135 |
| Neurocrine BioSciences, Inc. | 4 | $105 |
| Teva Pharmaceuticals USA, Inc. | 5 | $104 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $93 |
| Corium, LLC | 4 | $81 |
| Axsome Therapeutics, Inc. | 4 | $75 |
| Almatica Pharma LLC | 3 | $65 |
Products named: CAPLYTA, VRAYLAR, REXULTI, FANAPT, INGREZZA, TRINTELLIX, AUSTEDO XR, Azstarys.
Industry payments across AL — which companies pay providers there.
